20487 ⎘
Medicinal preparations containing organic active ingredients; Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
#902Method of treating ileus by pharmacological activation of cholinergic receptors
#903External preparation for treating painful skin wound
#904Prostate cancer treatment with glycogen synthase kinase-3beta inhibitors
#905External preparation for treating skin or mucosal injury caused by viral infection
#906Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment
#907Methods for performing percutaneous coronary intervention
#908Antiallergic agents
#909Antiallergic agents
#910Dipyridamole extended-release formulations and process for preparing same
#911Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#912Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
#913Pharmaceutical salts and polymorphs of a factor Xa inhibitor
#914Combination of acetylsalicylic acid and alpha-glucosidase inhibitors
#915Methods and compositions for inhibition of angiogenesis
#916Pharmaceutical co-crystal compositions
#917Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
#918Benzamides and related inhibitors of factor Xa
#919Compositions for reducing the incidence of drug induced arrhythmia
#920Medicinal compositions containing aspirin
#921Drugs for the arthritis treatment
#922Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
#923Pharmaceutical composition combining tenatoprazole and an anti-inflamatory agent
#924Blood vessel-growth promoter
#925Benzamides and related inhibitors of factor Xa
#926Method for treating a mammal by administration of a compound having the ability to release CO
#927Novel olanzapine forms and related methods of treatment
#928Methods of treating dry eye disorders
#929Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#930Enteric composition for the manufacture of soft capsule wall
#931Therapeutic agent for hemorrhoidal disease
#932Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
#933Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents
#934Antiallergic
#935Composition containing an association of aspirin and an anti-Xa oligosaccharide and use of an anti-Xa oligosaccharide optionally in combination with aspirin
#936Myeloperoxidase, a risk indicator for cardiovascular disease
#937Chewable enteric coated aspirin tablets
#938Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
#939Compositions for inducing of immunotolerance
#940Method of treating ischemia-reperfusion injury
#941Combination therapies employing platelet aggregation drugs
#942Medicament for treatment of cancer
#943Use of dipyridamole or mopidamole for treatment and prevention of MMP-9-dependent disorders
#944Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses
#945Benzamides and related inhibitors of factor Xa
#946Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#947Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
#948External preparation for inhibiting keloid formation
#949Methods and compositions for treating platelet-related disorders
#950Anti-bacterial plant compositions
#951Unit dose of material in system and method
#952Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#953Association of an antithrombotic and aspirin
#954Composition comprising an aqueous extract of red vine leaves and an antithrombotic agent
#955Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#956Compositions and methods for preventing sporadic neoplasia in colon
#957Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
#958Multi-system therapy for diabetes, the metabolic syndrome and obesity
#959Treatment and prevention of cardiovascular events
#960Pharmaceutical formulation
#961Stable salts of O-acetylsalicylic acid with basic amino acids
#962Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist
#963Aspirin-containing trasdermal pharmaceutical composition for the treatment of calcification
#964Method and system for reducing active ingredient potency in pain-management compositions to a quarter amount of approved levels
#965Compositions and methods for prevention and treatment of coronavirus and related disorders
#966Transparent water nanolipid fluid (DNLF) dispersions and method of preparation using a twin screw extruder
#967Substrates for vaporizing and delivering an aerosol
#968In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid (aspirin)
#969Pharmaceutical compositions of aspirin for parenteral administration
#970Targeted nanoparticles
#971Solid oral formulations having an iron sugar overcoat
#972Dry powder compositions with magnesium stearate
#973Compositions and methods for treating concussion
#974Methods and compositions using AMPK activators for pharmacological prevention of chronic pain
#975Method of preparing a nanocomposite film including starch nanofibers
#976Honey based biocide composition